← 產業報告目錄
Inhaled Nitric Oxide Delivery Device Industry Research Report 2026
出版商 APO Research產業別 Medical Devices出版日期 2026-07-04頁數 121報告編號 APO-8e41756be3
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Inhaled Nitric Oxide Delivery Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Inhaled Nitric Oxide Delivery Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Inhaled Nitric Oxide Delivery Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Inhaled Nitric Oxide Delivery Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Inhaled Nitric Oxide Delivery Device include Air Liquide Healthcare, Bellerophon Therapeutics, Beyond Air, Circassia Pharmaceuticals, Getinge, LINDE, Mallinckrodt Pharmaceuticals, NU MED and Praxair Technology Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Inhaled Nitric Oxide Delivery Device market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Inhaled Nitric Oxide Delivery Device Market by Company
Air Liquide Healthcare
Bellerophon Therapeutics
Beyond Air
Circassia Pharmaceuticals
Getinge
LINDE
Mallinckrodt Pharmaceuticals
NU MED
Praxair Technology Inc.
Vero Biotech
Inhaled Nitric Oxide Delivery Device Segment by Type
Inhaled Nitric Oxide Delivery Device for Children
Inhaled Nitric Oxide Delivery Device for Adults
Inhaled Nitric Oxide Delivery Device Segment by Application
Hypoxic Respiratory Failure (HRF)
Chronic Obstructive Pulmonary Disease (COPD)
Acute Hypoxemic Respiratory Failure (AHRF)
Others
Inhaled Nitric Oxide Delivery Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled Nitric Oxide Delivery Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inhaled Nitric Oxide Delivery Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled Nitric Oxide Delivery Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Inhaled Nitric Oxide Delivery Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Inhaled Nitric Oxide Delivery Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Inhaled Nitric Oxide Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Inhaled Nitric Oxide Delivery Device Market Size (2021-2032)
2.2.2 Global Inhaled Nitric Oxide Delivery Device Sales (2021-2032)
2.2.3 Global Inhaled Nitric Oxide Delivery Device Market Average Price (2021-2032)
2.3 Inhaled Nitric Oxide Delivery Device by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Inhaled Nitric Oxide Delivery Device for Children
2.3.3 Inhaled Nitric Oxide Delivery Device for Adults
2.4 Inhaled Nitric Oxide Delivery Device by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Hypoxic Respiratory Failure (HRF)
2.4.3 Chronic Obstructive Pulmonary Disease (COPD)
2.4.4 Acute Hypoxemic Respiratory Failure (AHRF)
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Inhaled Nitric Oxide Delivery Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Inhaled Nitric Oxide Delivery Device Sales (k units) of Manufacturers (2021-2026)
3.3 Global Inhaled Nitric Oxide Delivery Device Revenue of Manufacturers (2021-2026)
3.4 Global Inhaled Nitric Oxide Delivery Device Average Price by Manufacturers (2021-2026)
3.5 Global Inhaled Nitric Oxide Delivery Device Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Inhaled Nitric Oxide Delivery Device, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Inhaled Nitric Oxide Delivery Device, Product Type & Application
3.8 Global Manufacturers of Inhaled Nitric Oxide Delivery Device, Established Date
3.9 Global Inhaled Nitric Oxide Delivery Device Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Air Liquide Healthcare
4.1.1 Air Liquide Healthcare Company Information
4.1.2 Air Liquide Healthcare Business Overview
4.1.3 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Portfolio
4.1.5 Air Liquide Healthcare Recent Developments
4.2 Bellerophon Therapeutics
4.2.1 Bellerophon Therapeutics Company Information
4.2.2 Bellerophon Therapeutics Business Overview
4.2.3 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Portfolio
4.2.5 Bellerophon Therapeutics Recent Developments
4.3 Beyond Air
4.3.1 Beyond Air Company Information
4.3.2 Beyond Air Business Overview
4.3.3 Beyond Air Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Beyond Air Inhaled Nitric Oxide Delivery Device Product Portfolio
4.3.5 Beyond Air Recent Developments
4.4 Circassia Pharmaceuticals
4.4.1 Circassia Pharmaceuticals Company Information
4.4.2 Circassia Pharmaceuticals Business Overview
4.4.3 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
4.4.5 Circassia Pharmaceuticals Recent Developments
4.5 Getinge
4.5.1 Getinge Company Information
4.5.2 Getinge Business Overview
4.5.3 Getinge Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Getinge Inhaled Nitric Oxide Delivery Device Product Portfolio
4.5.5 Getinge Recent Developments
4.6 LINDE
4.6.1 LINDE Company Information
4.6.2 LINDE Business Overview
4.6.3 LINDE Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.6.4 LINDE Inhaled Nitric Oxide Delivery Device Product Portfolio
4.6.5 LINDE Recent Developments
4.7 Mallinckrodt Pharmaceuticals
4.7.1 Mallinckrodt Pharmaceuticals Company Information
4.7.2 Mallinckrodt Pharmaceuticals Business Overview
4.7.3 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
4.7.5 Mallinckrodt Pharmaceuticals Recent Developments
4.8 NU MED
4.8.1 NU MED Company Information
4.8.2 NU MED Business Overview
4.8.3 NU MED Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.8.4 NU MED Inhaled Nitric Oxide Delivery Device Product Portfolio
4.8.5 NU MED Recent Developments
4.9 Praxair Technology Inc.
4.9.1 Praxair Technology Inc. Company Information
4.9.2 Praxair Technology Inc. Business Overview
4.9.3 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Portfolio
4.9.5 Praxair Technology Inc. Recent Developments
4.10 Vero Biotech
4.10.1 Vero Biotech Company Information
4.10.2 Vero Biotech Business Overview
4.10.3 Vero Biotech Inhaled Nitric Oxide Delivery Device Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Vero Biotech Inhaled Nitric Oxide Delivery Device Product Portfolio
4.10.5 Vero Biotech Recent Developments
5 Global Inhaled Nitric Oxide Delivery Device Market Scenario by Region
5.1 Global Inhaled Nitric Oxide Delivery Device Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2021-2032
5.2.1 Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2021-2026
5.2.2 Global Inhaled Nitric Oxide Delivery Device Sales by Region: 2027-2032
5.3 Global Inhaled Nitric Oxide Delivery Device Revenue by Region: 2021-2032
5.3.1 Global Inhaled Nitric Oxide Delivery Device Revenue by Region: 2021-2026
5.3.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Region: 2027-2032
5.4 North America Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
5.4.1 North America Inhaled Nitric Oxide Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
5.4.3 North America Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
5.5.1 Europe Inhaled Nitric Oxide Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
5.5.3 Europe Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
5.6.1 Asia Pacific Inhaled Nitric Oxide Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
5.6.3 Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
5.7.1 South America Inhaled Nitric Oxide Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
5.7.3 South America Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Inhaled Nitric Oxide Delivery Device Market Facts & Figures by Country
5.8.1 Middle East and Africa Inhaled Nitric Oxide Delivery Device Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2032)
5.8.3 Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2032)
6.1.1 Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2032) & (k units)
6.1.2 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2021-2032)
6.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2032)
6.2.1 Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2021-2032)
6.3 Global Inhaled Nitric Oxide Delivery Device Price by Type (2021-2032)
7 Segment by Application
7.1 Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2032)
7.1.1 Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2032) & (k units)
7.1.2 Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2021-2032)
7.2 Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2032)
7.2.1 Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2021-2032)
7.3 Global Inhaled Nitric Oxide Delivery Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Inhaled Nitric Oxide Delivery Device Value Chain Analysis
8.1.1 Inhaled Nitric Oxide Delivery Device Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Inhaled Nitric Oxide Delivery Device Production Mode & Process
8.2 Inhaled Nitric Oxide Delivery Device Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Inhaled Nitric Oxide Delivery Device Distributors
8.2.3 Inhaled Nitric Oxide Delivery Device Customers
9 Global Inhaled Nitric Oxide Delivery Device Analyzing Market Dynamics
9.1 Inhaled Nitric Oxide Delivery Device Industry Trends
9.2 Inhaled Nitric Oxide Delivery Device Industry Drivers
9.3 Inhaled Nitric Oxide Delivery Device Industry Opportunities and Challenges
9.4 Inhaled Nitric Oxide Delivery Device Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Inhaled Nitric Oxide Delivery Device Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Inhaled Nitric Oxide Delivery Device Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Inhaled Nitric Oxide Delivery Device Revenue of Manufacturers (2021-2026)
Table 9. Global Inhaled Nitric Oxide Delivery Device Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Inhaled Nitric Oxide Delivery Device Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Inhaled Nitric Oxide Delivery Device Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Inhaled Nitric Oxide Delivery Device, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Inhaled Nitric Oxide Delivery Device, Product Type & Application
Table 14. Global Inhaled Nitric Oxide Delivery Device Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Inhaled Nitric Oxide Delivery Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Air Liquide Healthcare Company Information
Table 19. Air Liquide Healthcare Business Overview
Table 20. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. Air Liquide Healthcare Inhaled Nitric Oxide Delivery Device Product Portfolio
Table 22. Air Liquide Healthcare Recent Developments
Table 23. Bellerophon Therapeutics Company Information
Table 24. Bellerophon Therapeutics Business Overview
Table 25. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. Bellerophon Therapeutics Inhaled Nitric Oxide Delivery Device Product Portfolio
Table 27. Bellerophon Therapeutics Recent Developments
Table 28. Beyond Air Company Information
Table 29. Beyond Air Business Overview
Table 30. Beyond Air Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. Beyond Air Inhaled Nitric Oxide Delivery Device Product Portfolio
Table 32. Beyond Air Recent Developments
Table 33. Circassia Pharmaceuticals Company Information
Table 34. Circassia Pharmaceuticals Business Overview
Table 35. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. Circassia Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
Table 37. Circassia Pharmaceuticals Recent Developments
Table 38. Getinge Company Information
Table 39. Getinge Business Overview
Table 40. Getinge Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. Getinge Inhaled Nitric Oxide Delivery Device Product Portfolio
Table 42. Getinge Recent Developments
Table 43. LINDE Company Information
Table 44. LINDE Business Overview
Table 45. LINDE Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. LINDE Inhaled Nitric Oxide Delivery Device Product Portfolio
Table 47. LINDE Recent Developments
Table 48. Mallinckrodt Pharmaceuticals Company Information
Table 49. Mallinckrodt Pharmaceuticals Business Overview
Table 50. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. Mallinckrodt Pharmaceuticals Inhaled Nitric Oxide Delivery Device Product Portfolio
Table 52. Mallinckrodt Pharmaceuticals Recent Developments
Table 53. NU MED Company Information
Table 54. NU MED Business Overview
Table 55. NU MED Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. NU MED Inhaled Nitric Oxide Delivery Device Product Portfolio
Table 57. NU MED Recent Developments
Table 58. Praxair Technology Inc. Company Information
Table 59. Praxair Technology Inc. Business Overview
Table 60. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. Praxair Technology Inc. Inhaled Nitric Oxide Delivery Device Product Portfolio
Table 62. Praxair Technology Inc. Recent Developments
Table 63. Vero Biotech Company Information
Table 64. Vero Biotech Business Overview
Table 65. Vero Biotech Inhaled Nitric Oxide Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Vero Biotech Inhaled Nitric Oxide Delivery Device Product Portfolio
Table 67. Vero Biotech Recent Developments
Table 68. Global Inhaled Nitric Oxide Delivery Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 69. Global Inhaled Nitric Oxide Delivery Device Sales by Region (2021-2026) & (k units)
Table 70. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2021-2026)
Table 71. Global Inhaled Nitric Oxide Delivery Device Sales by Region (2027-2032) & (k units)
Table 72. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Region (2027-2032)
Table 73. Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2021-2026) & (US$ Million)
Table 74. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2021-2026)
Table 75. Global Inhaled Nitric Oxide Delivery Device Revenue by Region (2027-2032) & (US$ Million)
Table 76. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Region (2027-2032)
Table 77. North America Inhaled Nitric Oxide Delivery Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 78. North America Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026) & (k units)
Table 79. North America Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032) & (k units)
Table 80. North America Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2026) & (US$ Million)
Table 81. North America Inhaled Nitric Oxide Delivery Device Revenue by Country (2027-2032) & (US$ Million)
Table 82. Europe Inhaled Nitric Oxide Delivery Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 83. Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026) & (k units)
Table 84. Europe Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032) & (k units)
Table 85. Europe Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2026) & (US$ Million)
Table 86. Europe Inhaled Nitric Oxide Delivery Device Revenue by Country (2027-2032) & (US$ Million)
Table 87. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 88. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026) & (k units)
Table 89. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032) & (k units)
Table 90. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2026) & (US$ Million)
Table 91. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue by Country (2027-2032) & (US$ Million)
Table 92. South America Inhaled Nitric Oxide Delivery Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 93. South America Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026) & (k units)
Table 94. South America Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032) & (k units)
Table 95. South America Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2026) & (US$ Million)
Table 96. South America Inhaled Nitric Oxide Delivery Device Revenue by Country (2027-2032) & (US$ Million)
Table 97. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 98. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country (2021-2026) & (k units)
Table 99. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales by Country (2027-2032) & (k units)
Table 100. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Country (2021-2026) & (US$ Million)
Table 101. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue by Country (2027-2032) & (US$ Million)
Table 102. Global Inhaled Nitric Oxide Delivery Device Sales by Type (2021-2026) & (k units)
Table 103. Global Inhaled Nitric Oxide Delivery Device Sales by Type (2027-2032) & (k units)
Table 104. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2021-2026)
Table 105. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2027-2032)
Table 106. Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2021-2026) & (US$ Million)
Table 107. Global Inhaled Nitric Oxide Delivery Device Revenue by Type (2027-2032) & (US$ Million)
Table 108. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2021-2026)
Table 109. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2027-2032)
Table 110. Global Inhaled Nitric Oxide Delivery Device Price by Type (2021-2026) & (USD/unit)
Table 111. Global Inhaled Nitric Oxide Delivery Device Price by Type (2027-2032) & (USD/unit)
Table 112. Global Inhaled Nitric Oxide Delivery Device Sales by Application (2021-2026) & (k units)
Table 113. Global Inhaled Nitric Oxide Delivery Device Sales by Application (2027-2032) & (k units)
Table 114. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2021-2026)
Table 115. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2027-2032)
Table 116. Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2021-2026) & (US$ Million)
Table 117. Global Inhaled Nitric Oxide Delivery Device Revenue by Application (2027-2032) & (US$ Million)
Table 118. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2021-2026)
Table 119. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2027-2032)
Table 120. Global Inhaled Nitric Oxide Delivery Device Price by Application (2021-2026) & (USD/unit)
Table 121. Global Inhaled Nitric Oxide Delivery Device Price by Application (2027-2032) & (USD/unit)
Table 122. Key Raw Materials
Table 123. Raw Materials Key Suppliers
Table 124. Inhaled Nitric Oxide Delivery Device Distributors List
Table 125. Inhaled Nitric Oxide Delivery Device Customers List
Table 126. Inhaled Nitric Oxide Delivery Device Industry Trends
Table 127. Inhaled Nitric Oxide Delivery Device Industry Drivers
Table 128. Inhaled Nitric Oxide Delivery Device Industry Restraints
Table 129. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Inhaled Nitric Oxide Delivery Device Product Image
Figure 5. Global Inhaled Nitric Oxide Delivery Device Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Inhaled Nitric Oxide Delivery Device Market Size (2021-2032) & (US$ Million)
Figure 7. Global Inhaled Nitric Oxide Delivery Device Sales (2021-2032) & (k units)
Figure 8. Global Inhaled Nitric Oxide Delivery Device Average Price (USD/unit) & (2021-2032)
Figure 9. Inhaled Nitric Oxide Delivery Device for Children Product Image
Figure 10. Inhaled Nitric Oxide Delivery Device for Adults Product Image
Figure 11. Hypoxic Respiratory Failure (HRF) Product Image
Figure 12. Chronic Obstructive Pulmonary Disease (COPD) Product Image
Figure 13. Acute Hypoxemic Respiratory Failure (AHRF) Product Image
Figure 14. Others Product Image
Figure 15. Global Inhaled Nitric Oxide Delivery Device Revenue Share by Manufacturers in 2025
Figure 16. Global Manufacturers of Inhaled Nitric Oxide Delivery Device, Manufacturing Sites & Headquarters
Figure 17. Global Top 5 and 10 Inhaled Nitric Oxide Delivery Device Players Market Share by Revenue in 2025
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 19. Global Inhaled Nitric Oxide Delivery Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 20. Global Inhaled Nitric Oxide Delivery Device Sales by Region in 2025
Figure 21. Global Inhaled Nitric Oxide Delivery Device Revenue by Region in 2025
Figure 22. North America Inhaled Nitric Oxide Delivery Device Market Size by Country in 2025
Figure 23. North America Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2021-2032)
Figure 24. North America Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2021-2032)
Figure 25. United States Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Canada Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Mexico Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Europe Inhaled Nitric Oxide Delivery Device Market Size by Country in 2025
Figure 29. Europe Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2021-2032)
Figure 30. Europe Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2021-2032)
Figure 31. Germany Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. France Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. U.K. Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Italy Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Russia Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Spain Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Netherlands Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Switzerland Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Sweden Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Poland Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Asia Pacific Inhaled Nitric Oxide Delivery Device Market Size by Country in 2025
Figure 42. Asia Pacific Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2021-2032)
Figure 43. Asia Pacific Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2021-2032)
Figure 44. China Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Japan Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. South Korea Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. India Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Australia Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Taiwan Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. South America Inhaled Nitric Oxide Delivery Device Market Size by Country in 2025
Figure 53. South America Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2021-2032)
Figure 54. South America Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2021-2032)
Figure 55. Brazil Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Argentina Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Chile Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Middle East and Africa Inhaled Nitric Oxide Delivery Device Market Size by Country in 2025
Figure 59. Middle East and Africa Inhaled Nitric Oxide Delivery Device Sales Market Share by Country (2021-2032)
Figure 60. Middle East and Africa Inhaled Nitric Oxide Delivery Device Revenue Market Share by Country (2021-2032)
Figure 61. Egypt Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. South Africa Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. Israel Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Türkiye Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. GCC Countries Inhaled Nitric Oxide Delivery Device Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Type (2021-2032)
Figure 67. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Type (2021-2032)
Figure 68. Global Inhaled Nitric Oxide Delivery Device Price (USD/unit) by Type (2021-2032)
Figure 69. Global Inhaled Nitric Oxide Delivery Device Sales Market Share by Application (2021-2032)
Figure 70. Global Inhaled Nitric Oxide Delivery Device Revenue Market Share by Application (2021-2032)
Figure 71. Global Inhaled Nitric Oxide Delivery Device Price (USD/unit) by Application (2021-2032)
Figure 72. Inhaled Nitric Oxide Delivery Device Value Chain
Figure 73. Inhaled Nitric Oxide Delivery Device Production Mode & Process
Figure 74. Direct Comparison with Distribution Share
Figure 75. Distributors Profiles
Figure 76. Inhaled Nitric Oxide Delivery Device Industry Opportunities and Challenges
提及公司
Air Liquide HealthcareBellerophon TherapeuticsBeyond AirCircassia PharmaceuticalsGetingeLINDEMallinckrodt PharmaceuticalsNU MEDPraxair Technology Inc.Vero Biotech
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們